Progression after Chemotherapy Is a Novel Predictor of Poor Outcomes after Pulmonary Metastasectomy in Sarcoma Patients-Reference-Cited by-同舟云学术

Progression after Chemotherapy Is a Novel Predictor of Poor Outcomes after Pulmonary Metastasectomy in Sarcoma Patients

Published:2011-05 Issue:5 Volume:212 Page:821-826
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Stephens Elizabeth H.,Blackmon Shanda H.,Correa Arlene M.,Roth Jack A.,Rice David C.,Hofstetter Wayne,Benjamin Robert,Mehran Reza,Swisher Stephen G.,Walsh Garrett L.,Vaporciyan Ara A.

Publisher

Elsevier BV

Subject

Surgery

Reference26 articles.

1. Cancer Statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma;Gadd;Ann Surg,1993

3. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival;Billingsley;Ann Surg,1999

4. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases;Pastorino;J Thorac Cardiovasc Surg,1997

5. Analysis of prognostic factors in patients undergoing resection of pulmonary metastases from soft tissue sarcomas;Putnam;J Thorac Cardiovasc Surg,1984

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving survival after pulmonary metastasectomy for sarcoma: analysis of prognostic factors;General Thoracic and Cardiovascular Surgery;2023-01-12

2. How to treat liposarcomas located in retroperitoneum;European Journal of Surgical Oncology;2022-05

3. Impact of Intraoperative Molecular Imaging after Fluorescent-Guided Pulmonary Metastasectomy for Sarcoma;Journal of the American College of Surgeons;2022-04-15

4. Multidisciplinary Management of Retroperitoneal Sarcoma: Diagnosis, Prognostic Factors and Treatment;Cancers;2021-08-10

5. Surgery in soft tissue sarcoma: the thin line between a surgical or more conservative approach;Future Oncology;2021-07